Injection site reactions follow a predictable pattern that can be managed through rotation
Common sites for this method include the abdomen (at least two inches away from your belly button) or the fatty part of the thigh
Occasionally, addressing the underlying cause can alleviate gastroparesis
This means that many people need long-term or even lifelong treatment
Many people notice: Nausea or queasiness, especially early on Constipation or diarrhoea A noticeable drop in appetite, sometimes leading to rapid weight loss For most, these settle as the body adjusts, but the severity varies
Retatrutide is a synthetic research-grade peptide engineered to co-activate three specific G-protein coupled receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor